Rate control of phosphorylation-coupled respiration by rat liver mitochondria - PubMed (original) (raw)
Rate control of phosphorylation-coupled respiration by rat liver mitochondria
E J Davis et al. Arch Biochem Biophys. 1984 Sep.
Abstract
Liver mitochondria provided with an oxidizable substrate, ATP, oxygen, and an ADP-generating system (soluble F1-ATPase) were used to reevaluate the rate-controlling step(s) intrinsic to all of the processes of mitochondrial oxidative phosphorylation. The quantity termed "control strength" (C), previously defined as the fractional change in flux through a (system) induced by a fractional change in the concentration of an individual enzyme in the system, has been used to evaluate rate-influencing steps in this overall process by carefully defining the dimensions of the "system" under analysis. If the system is defined by a suspension of mitochondria provided with substrates, plus an extrinsic ADP-generating process (ATPase), the value of C of the latter for the overall process of phosphorylation-linked respiration is near 1.0 until the capacity of the mitochondria to phosphorylate ADP is approached, after which C for the soluble ATPase becomes zero as the maximum capacity for phosphorylation is attained. Carboxyatractyloside was found only marginally to inhibit respiration stimulated by ATPase, even when a large percentage of adenine nucleotide translocase molecules were immobilized. The relative lack of effect of carboxyatractyloside on phosphorylating respiration is explained by the readjustment of the concentration of one of the substrates (ADP) and an inhibitor (ATP), which results from inhibition of adenine nucleotide translocase. The residual blunted inhibition of respiration is explained by product inhibition of the ADP-regenerating ATPase, and not necessarily to any intrinsically mitochondrial intermediate process. The system being evaluated can be redefined to include only the processes intrinsic to mitochondria. This can be achieved by providing exactly comparable substrate concentrations to the mitochondria under comparable incubation conditions. Under these conditions, the adenine nucleotide translocase is the principal, if not the only, rate-controlling step in the overall process of oxidative phosphorylation until a new rate-limitation is attained (ATP synthesis). These data are consistent with the conclusion that, at intermediate rates of phosphorylation-coupled respiration, the extramitochondrial ATP/ADP ratio regulates this process through its kinetic effects on the catalytic properties of the adenine nucleotide translocase.
Similar articles
- Control of mitochondrial respiration. The contribution of the adenine nucleotide translocator depends on the ATP- and ADP-consuming enzymes.
Gellerich FN, Bohnensack R, Kunz W. Gellerich FN, et al. Biochim Biophys Acta. 1983 Feb 17;722(2):381-91. doi: 10.1016/0005-2728(83)90086-5. Biochim Biophys Acta. 1983. PMID: 6301555 - Dependence of mitochondrial oxidative phosphorylation on activity of the adenine nucleotide translocase.
Forman NG, Wilson DF. Forman NG, et al. J Biol Chem. 1983 Jul 25;258(14):8649-55. J Biol Chem. 1983. PMID: 6305996 - Control of mitochondrial respiration.
Tager JM, Wanders RJ, Groen AK, Kunz W, Bohnensack R, Küster U, Letko G, Böhme G, Duszynski J, Wojtczak L. Tager JM, et al. FEBS Lett. 1983 Jan 10;151(1):1-9. doi: 10.1016/0014-5793(83)80330-5. FEBS Lett. 1983. PMID: 6337871 Review. - Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply.
Gnaiger E. Gnaiger E. Respir Physiol. 2001 Nov 15;128(3):277-97. doi: 10.1016/s0034-5687(01)00307-3. Respir Physiol. 2001. PMID: 11718759 Review.
Cited by
- Ischemic damage to every segment of the oxidative phosphorylation cascade elevates ETC driving force and ROS production in cardiac mitochondria.
Kuzmiak-Glancy S, Glancy B, Kay MW. Kuzmiak-Glancy S, et al. Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H499-H512. doi: 10.1152/ajpheart.00129.2022. Epub 2022 Jul 22. Am J Physiol Heart Circ Physiol. 2022. PMID: 35867709 Free PMC article. - Site-specific acetylation of adenine nucleotide translocase 1 at lysine 23 in human muscle.
Finlayson J, Barakati N, Langlais PR, Funk J, Zapata Bustos R, Coletta DK, Luo M, Willis WT, Mandarino LJ. Finlayson J, et al. Anal Biochem. 2021 Oct 1;630:114319. doi: 10.1016/j.ab.2021.114319. Epub 2021 Jul 29. Anal Biochem. 2021. PMID: 34332952 Free PMC article. - Oxidative phosphorylation K0.5ADP in vitro depends on substrate oxidative capacity: Insights from a luciferase-based assay to evaluate ADP kinetic parameters.
Willis W, Willis E, Kuzmiak-Glancy S, Kras K, Hudgens J, Barakati N, Stern J, Mandarino L. Willis W, et al. Biochim Biophys Acta Bioenerg. 2021 Aug 1;1862(8):148430. doi: 10.1016/j.bbabio.2021.148430. Epub 2021 Apr 20. Biochim Biophys Acta Bioenerg. 2021. PMID: 33887230 Free PMC article. - Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
Tibullo D, Giallongo C, Romano A, Vicario N, Barbato A, Puglisi F, Parenti R, Amorini AM, Wissam Saab M, Tavazzi B, Mangione R, Brundo MV, Lazzarino G, Palumbo GA, Volti GL, Raimondo FD, Lazzarino G. Tibullo D, et al. Biomolecules. 2020 Apr 30;10(5):696. doi: 10.3390/biom10050696. Biomolecules. 2020. PMID: 32365811 Free PMC article. - Dominant and sensitive control of oxidative flux by the ATP-ADP carrier in human skeletal muscle mitochondria: Effect of lysine acetylation.
Willis WT, Miranda-Grandjean D, Hudgens J, Willis EA, Finlayson J, De Filippis EA, Zapata Bustos R, Langlais PR, Mielke C, Mandarino LJ. Willis WT, et al. Arch Biochem Biophys. 2018 Jun 1;647:93-103. doi: 10.1016/j.abb.2018.04.006. Epub 2018 Apr 10. Arch Biochem Biophys. 2018. PMID: 29653079 Free PMC article.